Placenta study to prevent repeat pregnancy complications
Part of Women’s health & pregnancy clinical trials.
This trial tests whether a blood-thinning medication (enoxaparin) can help prevent complications like preterm birth or preeclampsia from happening again. It is for people who had a past pregnancy problem tied to placenta blood flow issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a past pregnancy problem like preterm birth (before 37 weeks), a very small baby, severe preeclampsia, or stillbirth (after 20 weeks).
- A special pathologist confirmed that your placenta from that past pregnancy had blood flow problems (called maternal vascular malperfusion).
- You are currently pregnant with one baby and your pregnancy is less than 17 weeks along.
- You are not planning to take blood-thinning medication (like enoxaparin, warfarin, or heparin) for this pregnancy.
- You do not have certain health conditions like active bleeding, low platelets, severe kidney or liver disease, or a mechanical heart valve.
- You do not have a serious fetal abnormality known already.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people’s blood and clotting behave during pregnancy when taking a specific blood thinner called low molecular weight heparin (LMWH) three times a day. It may help doctors fine-tune how safely and effectively LMWH is used during pregnancy.
This trial tests whether a blood-thinning medication, enoxaparin, can improve outcomes for babies diagnosed with intrauterine growth restriction (poor growth) and too little amniotic fluid. It aims to see if treatment leads to better health for the baby at birth.
This trial compares two blood-thinning medicines, apixaban and enoxaparin, to see which works better at preventing dangerous blood clots after delivery. It is for women who have certain risk factors that make them more likely to get a clot.
This study tests whether giving a short course of a daily blood-thinning injection (enoxaparin) after childbirth can safely prevent blood clots in women at intermediate risk. If you qualify, you would receive the injection or a placebo (inactive shot) for up to 5 days while in the hospital.
This study looks at how the lining of the womb (the luteal phase) affects the placenta in early pregnancy. It aims to understand why some pregnancies have complications and may help improve care for future pregnancies.
This trial studies whether tranexamic acid can prevent heavy bleeding after a planned or urgent cesarean delivery in people with placenta previa. If you qualify, you may receive the study drug to help your body keep blood loss lower during and after surgery.
Hear when a new Adverse Pregnancy Outcome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.